STAT5A and acute myeloid leukemia: Constitutive activation of STAT5 is widely observed in AML, and mutations in NPM1 abrogating its normal function are found in one-third of AML patients.12, 13 Furthermore, the oncogenic properties of both STAT5 and NPM1 are tied to their nucleolar localizations.